Skip to main content
Signal8

enVVeno Medical Corp (NVNO)

enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

enVVeno Medical Corporation logo

enVVeno Medical Corporation

NASDAQ:NVNOHealthcare
-2.94%$5.77
CLOSED
AH$5.77+0.00%vs close
Mkt Cap$4.01M
EV-
Float691K
O/S695K
VOL11K sh
$ Vol$65K
RVOL0.34×
Inst Own12.6%
Net Cash/Sh-
Dilution
enVVeno Medical Corporation logoNASDAQ:NVNOClosed$5.77-2.94%

enVVeno Medical Corp (NVNO) dilution facts from SEC filings

Snapshot as of Sep 30, 2026, built from 28 SEC filings.

Shelf registration
S-3 filed Aug 21, 2026, effective Sep 10, 2026
Source: S-3 filed Aug 21, 2026
At-the-market (ATM) program
Yes, sales agreement dated Oct 30, 2025
Source: 10-Q filed Oct 29, 2026
Warrants outstanding
4 warrant series recorded as outstanding
Most recent offering
Not measured

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro